A detailed history of Bank Plus Trust Department transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Bank Plus Trust Department holds 34,099 shares of BMY stock, worth $1.6 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
34,099
Previous 34,261 0.47%
Holding current value
$1.6 Million
Previous $1.59 Billion 3.03%
% of portfolio
0.41%
Previous 0.47%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 17, 2025

SELL
$43.31 - $48.98 $7,016 - $7,934
-162 Reduced 0.47%
34,099 $1.54 Billion
Q2 2025

Jul 23, 2025

BUY
$44.12 - $59.6 $158,170 - $213,666
3,585 Added 11.69%
34,261 $1.59 Billion
Q1 2025

May 01, 2025

BUY
$53.9 - $63.11 $178,948 - $209,525
3,320 Added 12.14%
30,676 $1.87 Billion
Q4 2024

Feb 04, 2025

BUY
$51.92 - $59.94 $1.42 Million - $1.64 Million
27,356 New
27,356 $1.55 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $99.5B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Bank Plus Trust Department Portfolio

Follow Bank Plus Trust Department and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Plus Trust Department, based on Form 13F filings with the SEC.

News

Stay updated on Bank Plus Trust Department with notifications on news.